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C. elegans has emerged as an invaluable model organism for in vivo neurobiology 
research to understand disease mechanisms and pathology relevant in humans. Simple 
anatomy, short lifecycle, fully characterized genome, and miniature body scale make 
these nematodes an ideal model organism for phenotyping and bio-molecular studies 
using microfluidic platforms. Advancements in soft-lithography have improved the 
functionality of microfluidic technology for C. elegans, leading to whole organism 
studies in high-throughput manner that were not otherwise possible.  
In order to study phenomena that require large amounts of data such as drug 
screens for neurological disorders and phenotyping, high-throughput imaging platforms 
with high-speed, high-resolution image acquisition become essential. With this in mind, 
we have developed and tested microfluidic immobilization devices to enable high-
throughput optical interrogation of C. elegans for neurodegenerative diseases and large 
scale drug screens. Initially, we designed, developed, and tested single-layer and double-
layer SU8 mold PDMS chips with parallel tapered channels to immobilize 40 adult C. 
elegans for high-resolution fluorescence imaging of their neurons in a parallel manner. 
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We achieved over 90% immobilization efficiency using these initial devices, but could 
achieve only ~50% of the trapped worms with proper orientation to allow scoring of the 
VC neurons of interest. To improve worm orientation, we developed a three-layer 
microfluidic chip that can immobilize and orient the adult worms for optical interrogation 
of these VC neurons with 90% efficiency. Finally, we scaled the platform to 
accommodate a large scale platform with standard multi-well format on-chip wells where 
each well leads to the optimized trapping channels.  
The final optimized multi-well platform provides comprehensive easy to use 96-
well microfluidic system to orient, immobilize, and image adult C. elegans in high-
throughput manner. The novel gasket system can pressurize the multi-well device pre-
loaded with 96 individual worm populations. Using a sequence of on-off applied gasket 
pressure, we can orient and immobilize worms in all 96 devices simultaneously in less 
than 5 minutes. Custom designed software can capture 12 z-stack images per worm from 
all 96-well in less than 12 minutes. With 95% trapping efficiency, approximately 90% of 
the worms can be scored successfully for neuronal phenotyping of VC neurons. This 96-
well platform and the automated imaging system enable high-throughput optical 
interrogation of adult C. elegans for large-scale drug screens relating to ageing and 
various neurodegenerative diseases.
 vii 
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CHAPTER ONE: INTRODUCTION 
 Neurodegenerative diseases pose an enormous financial and emotional burden on 
the world. In 2010, 35.6 million people were estimated to have dementia, resulting in a 
worldwide economic burden of $604 billion US dollars annually [1,2]. Not only are these 
estimates conservative based on the financial earnings from serious mental illness, but 
they do not take into account the suffering and huge emotional encumbrance on the 
patients, families, and caregivers. While the general life expectancy of the world 
continues to rise, the occurrence of age-related neurodegenerative diseases will continue 
to escalate. Therefore, identifying potential drug targets rapidly as well as understanding 
the fundamental basis of neurodegenerative diseases could significantly accelerate the 
detection of new treatments and therapies for these ailments.  Our research group has 
been developing optical and microfluidic techniques to enhance the study of 
neurodegenerative diseases in the nematode, Caenorhabditis elegans (C. elegans). 
Over the past 30 years, C. elegans has moved to the forefront of developmental 
biology and neurobiology research relating to humans [3]. C. elegans is an ideal model 
organism for high-throughput in vivo studies of bio-molecular phenomena due to its short 
lifecycle, fully sequenced genome, and fully stereotyped neuronal wiring. The numerous 
experiments enabled by C. elegans, combined with the inexpensive cost and ease of 
cultivating these nematodes in large numbers, have led to them becoming a widely used 
model organism in research labs, pharmaceutical labs, and environmental agencies 
around the world. Over the past ten years, three Nobel Prizes (in Physiology, Medicine, 
and Chemistry) have been awarded to researchers studying C. elegans. 
Microfluidic technologies have become a ubiquitous tool in chemical and life 
sciences over the last two decades. Microfluidics have helped to increase the throughput 
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and precision of experiments with C. elegans, enabling important neurobiology 
investigations [4] and  many experiments that are otherwise impossible. The next 
generation of microfluidic devices for these experiments should be easy to use, simple to 
connect between the macro and micro world, and allow a much greater throughput to 
gather large amounts of data, useful for high-throughput drug screens (why is large 
amount of data important for aging studies?). With this in mind, we have developed, 
designed, fabricated, and tested microfluidic devices to enable high-throughput optical 
interrogation of C. elegans for neurodegenerative diseases and large scale drug screens. 
First, we developed a simple single-layer microfluidic device from molded 
polydimethylsiloxane (PDMS) to immobilize and image Day 3 adult C. elegans. The 
device consists of an array of 40 tapered parallel traps, each to immobilize a single adult 
C. elegans for fluorescent imaging and observation without using anesthetics. A wedge 
shaped clamping device developed by Hulme et al. [5] could achieve ~90% 
immobilization with 126 parallel traps but required approximately 15 min to complete the 
loading process due to its branching geometry. With our single layer device, nearly 50% 
of are found to be oriented in an unfavorable position for imaging. This study led to our 
development of a two-layer and subsequently a three-layer SU8 mold PDMS device, the 
goal of which is to not only rapidly immobilize the adult C. elegans, but to 
simultaneously orient them laterally during the filling of the traps. These goals were 
successfully achieved using the three-layer SU8 mold PDMS device with specific aspect 
ratio design for the immobilization channels. Next, we began to develop a multi-well 
format to connect the devices for high-throughput investigations. We began by designing 
a two-well PDMS device using a well plate format. Each well, which was built into the 
chip, led to 40 immobilization channels, separated by 9 mm spacing, and the trapping 
channels of two wells connected to a single common exit. We further expended the chip 
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to include 8-wells and 16-wells. In the 16-well platform every 8 wells connected to a 
single common exit. The wells were pressurized from a single pressure source with a 
custom built gasket. After theoretically optimizing the flow characteristics and 
redesigning the exit channels for the 16-well platform, we were able to obtain similar 
flow rates from each well and successfully orient, immobilize, and image greater than 
90% of the loaded worms. 
Finally, using the optimized 16-well platform, we developed a comprehensive 
easy to use 96-well microfluidic system for high-throughput orientation, immobilization, 
and imaging of adult sized C. elegans.  To control, align, and house the device, we 
designed and built a novel gasket system that inserts directly into the microscope stage. 
Using this system, we can orient and immobilize the worms from all 96 devices 
simultaneously using a single pressure source. In order to acquire high resolution z-stack 
images from all the devices rapidly, in a parallel effort, our group developed a custom 
built LabVIEW algorithm to control the motion of a high speed microscope stage and a 
large field-of-view camera. Utilizing this algorithm, we were able to attain high 
resolution z-stack images of all 3,840 animals with our inverted fluorescent microscope 
in less than 12 minutes. This 96-well platform and system enables high-throughput 
optical interrogation of adult C. elegans for large-scale drug screens relating to aging, 
Alzheimer’s disease, Huntington’s disease, and many other neurodegenerative disorders. 
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CHAPTER TWO: MOTIVATION AND BACKGROUND  
 C. elegans have emerged as an invaluable model organism for in vivo high-
throughput neurological and biological research relating to humans. C. elegans are 
miniature, optically transparent, non-parasitic roundworms that are found in temperate 
soil environments around the world. They are the first multicellular organism to have its 
genome completely sequenced and the only organism to have its neuronal wiring diagram 
(connectome) completed. These traits, combined with the short life cycle and the 
inexpensive cost and ease of cultivating these nematodes in large numbers, make them an 
ideal model organism. Furthermore, because the body length scales of C. elegans are on 
the order of microns to around a millimeter, these nematodes are easily and quickly 
manipulated in microfluidic devices. 
Microfluidics technology has emerged as a powerful tool to increase the 
throughput and precision of experiments with C. elegans, enabling many important 
neural cell biology investigations [4] that are otherwise impossible. Recent advancements 
in soft-lithography that improve functionality and adaptability of microfluidic technology 
for C. elegans has led to whole organism high throughput and high resolution studies that 
were not possible otherwise [6]. Various other microfluidic technologies have been 
demonstrated for C. elegans involving sorting [7], long-term culture [8,9], fluorescent 
based screening [10-12], three-dimensional imaging [13,14], time-lapse imaging with 
optical manipulation [15], and other integrated microfluidic platforms [16]. These devices 
range from single channel to more complex designs with multiple layers for high-
resolution imaging and phenotyping using fluorescent markers. C. elegans provides an in 
vivo model with a high level of complexity that resembles disease pathology in humans, 
which is advantageous for understanding disease mechanisms and progression, and for 
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elucidating disease pathways [17-20]. C. elegans have made large contributions to the 
biological study of ageing using the WormFarm [8] and anti-aging role of polydatin [9]. 
Real time drug screening in C. elegans [21], serially orienting worms to study neuronal 
processes for developmental defects [9], immobilization of worms using wedged shaped 
channels [5], laterally orienting worms [10], stress response and study of physiological 
process of individually confined worms (WormSpa) [22], and liquid culture high 
throughput screening of C. elegans [23-25] have been demonstrated, with many using 
microfluidic devices. The next generation of microfluidic devices for these experiments 
should be easy to use, simple to connect between the macro and micro world, and allow a 
much greater throughput for gathering large amounts of data. With this in mind, we have 
designed, developed, and tested microfluidic devices to enable high-throughput optical 
interrogation of C. elegans for neurodegenerative diseases and large scale drug screens. 
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CHAPTER THREE: EXPERIMENTAL ASPECTS 
In this chapter we present the specific scientific and technological details relevant 
to the work presented in this thesis. We will discuss the C. elegans stains used as well as 
their culturing techniques for large numbers for high-throughput studies. Then we will 
discuss the microscope stage and optical imaging setup used for the study. Next, we will 
demonstrate the fluid dynamic modeling for our microfluidic devices. Finally, we will 
discuss the fabrication method for our microfluidic devices and device flow rate 
characterization methods. These technologies, combined with the speed and facility of 
using C. elegans as a model organism, will enable high-throughput investigations and 
screens that can lead to discovery of new drug compounds and significant progress in 
understanding the mechanism of neurodegenerative diseases. 
3.1 C. elegans strains and culturing techniques 
 We used two C. elegans strains for our Alzheimer’s disease study. LX959 and 
JPS67 worms were used as the wild type and APP mutant strain respectively [26]. In both 
of these strains, the motor neurons VC1-VC6 were marked with green fluorescent 
proteins (GFP) that can be visualized using fluorescent microscopy. The strains of C. 
elegans were initially grown and maintained on nematode growth medium (NGM) agar 
plates with HB101 bacteria at 20 °C according to the standard methods [27]. 
High-throughput drug screens using C. elegans require worm culturing and liquid 
handling in large quantities and in parallel. It is difficult to grow large numbers of C. 
elegans on NGM plates in laboratory environments. The difficulties in growing these 
large quantities for drug screens range from maintaining a food supply for each drug 
compound until the worms reach the adult stage, non-uniform drug exposure over time on 
a two dimensional habitat, altered food concentration with time, and the need for multiple 
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worm transfers during one single experiment. To overcome these challenges, we adopted 
liquid culture maintenance of C. elegans and modified the protocol to suit our need for 
drug treatments.  
C. elegans strains are maintained and synchronized at 20 °C for large population 
of liquid culture worms for high throughput studies in devices. Four healthy larval stage 4 
(L4) hermaphrodite are transferred to a 10 cm diameter NGM plate containing HB101 
bacterial lawn at 20 °C. The plate produces ~900-1000 gravid worms in 7 days which is 
then bleached to obtain ~6000 viable eggs on bleaching. The bleached eggs are incubated 
at 20 °C in a 360 degree rotor for 24 hours for all the eggs to hatch and obtain age 
synchronized larval stage 1 (L1). Hatched L1s are cleaned by filtering through a 20 m 
filter that separated healthy L1s from unhatched eggs, unhealthy/dead L1s, and worm 
carcasses present in the liquid. Healthy L1s are collected in a glass tube and centrifuged 
at 1000 rpm for 2 min to achieve a worm density of ~100 worms/10 L of liquid. A 
volume of 20 L is dispensed in 32 wells of 24-well plates with an additional 1 mL of 
HB101 bacterial food in S. medium (1x10
9
 cells/mL). The worms are incubated at 20 °C 
and shook at 80 rotations per min (rpm) for 48 hours until they reach late L4 stage. The 
well plate is left on a horizontal surface for 10 min for the worms to sink down to the 
bottom of the well. 1 mL of freshly suspended HB101 is added in every well. 50 mL of 
FUDR (8.4 mM in water) is added to every well to avoid production of new young 
worms in the well volumes. Appropriate drug compounds are added in designated wells 
at known concentrations. The plates are incubated for 72 hours until the worms grow to 
day 3 adult (D3) stage. Each well of the 32 wells are dispensed to three wells on a 96 well 
plates with a 40 m filter sieve. Worms are filtered, rinsed, and transferred to a fresh 96-
well collection plate. Finally, the worms are pipetted from individual wells to the wells of 
a primed device to be used for imaging using high-throughput screening platform.  
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3.2 Optical imaging setup and stage 
All bright field and fluorescent images are acquired using an Olympus IX73 
inverted microscope equipped with a 4 megapixel large field of view CCD camera 
(Princeton Instruments). Images are acquired using 2x (0.06 NA) and 10x (0.3 NA) 
objectives for bright field and fluorescence imaging, respectively. The fluorescent 
imaging system consists of a mercury lamp and a GFP filter set. The excitation filter and 
the emission filter transmit wavelength ranges of 460-500 nm and 510-560 nm 
respectively. We utilize an in-house LabVIEW program to move a motorized stage with a 
flat-top XY translational stage and a high resolution piezo stage for Z movement. The 
custom LabVIEW program controls the stage and camera to acquire and save z-stack 
fluorescent images for all 40 immobilization channels in each chip for the whole 96-well 
device. A full 96-well device generates 4608 fluorescent z-stack images (~40 GB of 
images) in less than 12 minutes. 
3.3 Fluid dynamic modeling of flows in microfluidic chips 
The design and development of microfluidic chips require prior device 
experiences and modifying devices in conjunction with analytical and empirical 
mathematical modeling using fluid mechanics to meet our experimental need. The basic 
conceptual chip design and its layout is guided by experience from prior published work 
by our group [28] and other microfluidic researchers [5], while mathematical models 
allow us to optimize fluid flow profiles and flow rates. 
In order to calculate the necessary fluid flow characteristics for a microfluidic 
system, one can reduce the system to a fluidic circuit using the Hagen-Poiseuille law, 
discussed later in this section [29]. Figure 3.3.1 displays a basic fluidic circuit model of a 
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microfluidic system with flow driven by a constant pressure source. The fluidic 
resistances of all the major components are calculated based on their geometries as well 
as the pressure drop across each component. The inlet to the system can be given a 
designated pressure and the outlet gauge pressure is assumed to be zero (atmospheric 
pressure). Once the fluidic pressure entering the chip is determined, the expected flow 
rates and velocities within a given microfluidic system can be calculated using analytical 
mathematical models. 
       
Figure 3.3.1: Fluidic circuit model.  
Schematic of a basic fluidic circuit model of a microfluidic system with flow driven by a 
constant pressure source. A fluid source under a constant known gauge pressure is fed to 
the chip from tubing and then exits the chip through additional tubing to atmospheric 
pressure. Rtubing is the fluidic resistance of the tubing either before or after the chip. Rchip 
is the total fluidic resistance of the microfluidic device. 
An important fluid mechanics parameter to consider in the design of microfluidic 
devices is the Reynolds number. The value of the Reynolds number is a ratio of the 
inertial forces to the viscous forces and is determined by Eq. (1). 
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      (1)  
Here,   is the density of the fluid, d is the diameter of the given tube, Q is the volumetric 
flow rate of the fluid,   is the viscosity of the fluid, and A is the cross-sectional area of 
the tube. High Reynolds numbers (>2000) generally indicate that turbulent mixing will 
occur within the fluid. Low Reynolds numbers generally indicate laminar flow, or 
streamline flow, which is when fluid in a channel or tube travels in parallel layers with no 
mixing between layers. Low Reynolds numbers are often expected at microfluidic length 
scales and fluid velocities, so laminar flow profiles tend to dominate [30]. 
Fluidic resistances for the tubing connections, which externally interface into the 
microfluidic chip, are estimated from the characteristic equations describing fully 
developed laminar flow of a Newtonian fluid in a circular tube, as shown in Eq. (2) 
  
     
   
      (2)  
Here,   is the fluid viscosity, L is the length of the tube, and d is the diameter of the tube. 
Since the resistance has a 1/d
4
 dependence on the tube diameter, small changes of the 
diameter can lead to significant changes in fluidic resistances. 
For our microfluidic device, the fluidic resistance across the micro-channels is 
determined using an alternative method, since the channels have rectangular cross-
sections with dimension on the order of tens of microns. In order to get an analytical 
solution for the fluid resistance of micro-channels, we solve the Navier-Stokes equations 
for an incompressible, isothermal, isotropic liquid flow with no slip boundary conditions 
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at the rectangular walls. The final expression to estimate microfluidic resistance in a 
rectangular cross-section, as described in [30], is shown below. 
  
    
   
[  
 
 
(
   
  
∑      (
   
  
)        )]
  
  (3)  
Here, h is the height and w is the width of the rectangular channel. L is the length of the 
channel section for which we are calculating the resistance and   is the viscosity of the 
fluid.  We will continue to utilize Eq. (3) for our resistance calculations. For the devices 
and tubes used in our experiments and discussed in this thesis, the resistance of the tubing 
leading to the devices are calculated to be less than 0.1 % of the resistance of the entire 
chip due to the large difference in the cross-sectional dimensions within the channels of 
the device versus the tubing diameters. 
With the fluidic resistances calculated based on device geometries and the known 
pressure drop across the entire system, we calculate the flow rate of the system using the 
Hagen-Poiseuille Law [29]. The parameters are related to each other by the simple fluidic 
circuit model shown in Eq. (4), 
           (4)  
where    is the pressure drop, Q is the volumetric flow rate, and R is the fluidic 
resistance across the particular channel. Using this relation, we can then calculate the 
pressure drop and flow rate through each resistance element throughout the entire chip 
design. 
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3.4 Microfluidic device fabrication 
Our microfluidic devices are fabricated using three-layer photo-lithography and 
soft-lithography techniques. We first designed the photo masks using AutoCAD 2013 and 
had them printed on transparencies using 40K DPI resolution laser-plotter (Fineline 
Imaging). In brief, a 6 inch silicon wafer is first spin coated with SU8-2025 photoresist 
(Microchem Corp.) at 2100 revolutions per minute (rpm) for 33 seconds to obtain a 
uniform height of ~45 µm (Layer-1, red). The layer is exposed to UV light using a photo-
mask with the pattern for layer-1 (mask-1), as displayed in Figure 3.4.1 (A). This layer is 
hard baked and developed to remove the unexposed SU8 photoresist. A second layer of 
SU8-2025 is spin coated at 1900 rpm for 33 seconds to obtain a height of ~65 µm (Layer-
2, green). The second layer is exposed to UV light using a photo-mask with the pattern 
for layer-2 (mask-2), as shown in Figure 3.4.1 (B). This layer is then hard baked and 
developed to remove the unexposed SU8 photoresist from layer-2. A third layer of SU8-
2035 photoresist (Microchem Corp.) is spin coated at 1650 rpm for 33 seconds to obtain a 
height of ~85 µm (Layer-3, blue). The third layer is then exposed to UV light with a 
photo-mask with the pattern for layer-3 (mask-3), as displayed in Figure 3.4.1 (C). The 
third layer is hard baked and developed to remove the unexposed SU8 photoresist from 
layer-3. The SU8 mold with all three layers is treated with tridecafluoro-1,1,2,2-
tetrahydrooctyl-1-trichlorosilane vapor (United Chemical Technologies) in a vacuum 
chamber at -67 KPa and 40 °C to create a hydrophobic layer to reduce surface adhesion 
during the soft-lithography process. 
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Polydimethylsiloxane (PDMS, Dow Corning) is mixed at a ratio of 10:1 (base to 
curing agent) and poured on the silanized SU8 mold with a 96-well PCR plate positioned 
on top of the SU8 features such that every well is aligned and placed on top of the 
circular pad at the entrance of every parallel immobilization device. The PCR plate is 
also pre-coated with silane vapor in a vacuum chamber to ease its release after the PDMS 
has cured. An acrylic outer mold (acr) is placed on the silicon substrate with SU8 features 
to restrict outer dimensions of the PDMS mold and achieve a device height of around 8 
mm of PDMS, as shown in Figure 3.4.1 (D). The PDMS layer is cured at 70 °C for 2 
hours, peeled off from the SU8 mold, and released from the PCR plate. The PDMS block 
is punched for the 12 designated exits and for the bottom of all 96 wells using a manual 
punching machine (Accu-Punch MP10-UNV, Syneo). The PDMS block is then cleaned 
and bonded to a 1/8 inch borosilicate glass substrate via oxygen plasma treatment of 110 
Watts. The bonded device is cured at 70 °C for 6 hours to enhance the glass to PDMS 
bonding, shown in Figure 3.4.1 (E). 
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Figure 3.4.1: Three-layer microfluidic device fabrication. 
Schematic of device fabrication. Multi-layer photo-lithography is used to fabricate Layer-
1 (A), Layer-2(B), and Layer-3 (C) out of SU8 photo-resists on a silicon wafer using high 
resolution plotted masks, mask-1, mask-2, and mask-3 respectively. The three layers are 
exposed and developed for three different heights (~45 µm, ~65 µm, and ~85 µm 
respectively) to obtain desired aspect ratios on the silicon wafer. (D) PDMS 10:1 mixture 
is poured on the SU8 layered silicon mold using an acrylic support (Acr) and a silane 
vapor treated 96-well PCR conical tubes for well structures on top of the well pads at the 
entrance to each device. (E) PDMS mold is cured at 70 °C for 2 hours, peeled off from 
the silicon substrate, removed from the 96-well PCR plate, punched with holes for 
external connections, and bonded to a 1/8 inch glass substrate.  
3.5 Flow rate characterization 
For flow rate measurements, PDMS devices are fabricated from the three-layer 
mold with input punches to be able to insert a metal coupler for flow input. A pressure 
buffer line at 10 psi is connected to one of the devices while all other inlets are blocked 
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using metal plugs. The device is primed to remove any air bubbles using the pressurized 
inlet with a blocked exit line for 30 minutes. Flow rates are measured by collecting buffer 
through the exit for 20 seconds at every pressure value (2.5, 5.0, 7.5, and 10.0 psi). This 
output volume is collected at least three times for every device and pressure value. Exit 
number 3 connecting well number A05-D06 of a 96-well device with the gasket system is 
opened to collect the volume of buffer from all 8 wells connected with the same exit. 
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CHAPTER FOUR: PARALLEL IMMOBILIZATION 
MICROFLUIDIC DEVICES FOR HIGH-THROUGHPUT 
NEURONAL DEGENERATION STUDIES IN C. ELEGANS 
In this chapter, we describe the design considerations that led to the optimized 
parallel immobilization microfluidic devices for optical interrogation and 
neurodegenerative studies in C. elegans. We discuss 1), the initial work using single layer 
tapered immobilization traps and our first design, 2) the subsequent double-layer mold 
design and our associated challenges, and 3) the triple-layer mold devices and the design 
considerations that led to the optimized trapping region. We discuss the design and 
testing of connecting many chips together in a multi-well format in order to greatly 
increase the speed and throughput of device. We then discuss the novel gasket system 
used to deliver liquid pressure to each population in a 96-well device from one pressure 
source. Finally, we describe the total device assembly and flow of the experimental 
procedure. 
4.1 Overview of design considerations 
 Microfluidic devices have enabled many neurological and biological 
investigations using C. elegans as a model that would have been otherwise impossible. 
Our goal is to develop the next generation of microfluidic devices that are easy to use, 
simple to connect between the micro and macro world, and allow a much greater 
throughput to gather large amounts of data. Whiteside’s group has initially demonstrated 
a microfabricated array of wedge shaped clamps used to immobilize and image live C. 
elegans [5]. While this device is able to successfully immobilize and acquire low 
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magnification bright field images of trapped worms, its branching network of channels 
takes a long time to load and immobilize worms. The orientation of the worms is 
uncontrolled, which can be unfavorable for imaging. Our research group has previously 
demonstrated a parallel microfluidic device for nerve regeneration studies of L4 stage C. 
elegans [28]. This PDMS device has no branching network connecting to the 
immobilization channels and allows for much faster loading. Our initial device for optical 
interrogation of day 3 adult C. elegans utilized this same design with increased 
dimensions to allow the much larger and older worms to be properly immobilized. We 
found one inherent problem associated with all of these devices; more than half of the 
immobilized worms are not oriented in a lateral posture suitable for obtaining high 
quality images of the desired VC neurons. This led to our development of a double-layer 
device, the goal of which is to not only rapidly immobilize the adult C. elegans, but to 
simultaneously control the orientation of the nematode during the filling of the traps. Our 
double-layer device can rapidly load and immobilize adult C. elegans for fluorescent 
imaging without anesthetics, but only half of the worms are oriented correctly for 
imaging. Finally, we designed a three-layer device with suitable aspect ratios for the 
trapping channels that successfully and rapidly loads, orients, and immobilizes the day 3 
adult C. elegans in a favorable orientation for fluorescent imaging. 
Each of our triple-layer microfluidic chips contains 40 parallel trapping channels. 
In order to create a device that is high throughput and easy to load, we designed and 
tested connecting many chips together in a multi-well format. Few research groups have 
developed well plate based devices for cell studies where a well plate with machined 
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access holes is bonded on top of a thin polymer microfluidic device such that each well 
connects to a single liquid input site to each chip [31, 32]. Loading liquid samples 
containing cells, C. elegans, or chemicals into a well using a pipette is much easier and 
faster than plugging a syringe to a tube with a metal coupler into every small hole leading 
to a microfluidic device. We decided to design our multi-well devices based on the 
common 96-well plate format whose design is already utilized by many robotic devices 
and liquid handling systems. Instead of machining and utilizing a solid plastic well plate 
bonded to our chips, we use a section (or the entirety) of a 96-well plate as an upper mold 
when fabricating our PDMS devices. Each well is built into the PDMS device and 
connects to the entrance of a single chip. We began by designing and testing a 1x2-well 
device with two chips connected symmetrically to a common exit. Then we developed a 
4x2-well device where eight chips, connected in a series of four pairs, connect to a single 
common exit. After optimizing the output flow rates for different chip locations, we 
developed and tested a final 96-well device that consisted of 12 eight-well devices 
leading to 12 exits on the boundaries of the device. 
While microfluidic technologies have enabled fast and automated control of 
biological and chemical samples with great precision, wide-spread adoption of 
microfluidics in relevant research areas has been hindered by the lack of a simplified 
interface between the macro and micro world. Our 96-well device helps to mitigate this 
hindrance by allowing easy sample handling and loading into each of the 96 microfluidic 
chips. In order to achieve a superior yet simple interface to control the device, we have 
designed and developed a novel gasket system. This gasket system allows for fluid 
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control and immobilization of the worms in all 96 chips using a single pressure source. 
The device is operated using filtered M9 from a 500 mL reservoir pressurized by 
compressed air. The pressure is transmitted to the top gasket through a computer 
controlled solenoid valve.  
The device assembly and loading methods for our investigation have been 
optimized to achieve the most simple and robust high-throughput experimental 
procedure. We have divided the flow of this procedure into three steps: liquid culture 
worm maintenance, device/worm preparation and immobilization, and image acquisition 
with data analysis. Utilizing our device assembly, we are able to load and immobilize 
worms in all 3840 channels in less than 5 minutes with greater than 90% of the loaded 
worms oriented correctly. Using our automated stage movement and image acquisition 
algorithm, we can collect all 4608 (~40 GB) z-stack images of the entire device in less 
than 12 minutes. 
4.2 Microfluidic designs and testing 
In the following section, we describe the microfluidic designs starting with the 
simplest device and progressing to the final design used for our high-throughput 
platform. We present and describe our single-layer device, our three different double-
layer devices, and our final triple-layer device with optimized aspect ratio for trapping 
channels.  
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4.2.1  SINGLE-LAYER PARALLEL IMMOBILIZATION MICROFLUIDIC DEVICES 
Our first design is a simple one-layer microfluidic PDMS chip fabricated using a one-
layer SU8 mold on a silicon wafer. The device consists of an array of 40 tapered parallel 
traps, each to immobilize a single adult C. elegans for fluorescent imaging and 
observation without the use of anesthetics. Figure 4.2.1.1 (A) displays a 0.7x 
magnification stereoscope image of the one-layer chip. The chip has one main entrance 
that fans out to the opening of the 40 parallel traps. There is a single exit connected to 
atmospheric pressure and a purge line to remove untrapped worms from the device. 
Figure 4.2.1.1 (B) displays a schematic representing the channel entrance and exit 
dimensions as well as the channel height throughout the device. As worms are pressed 
into the trapping region from a pressure source such as a syringe or pressurized fluid 
reservoir, the tapering of the width along the channel’s length allows for the 
immobilization of day 3 adult C. elegans. Figure 4.2.1.1 (C) displays an image of the 
single-layer chip containing 40 immobilized worms in parallel ready for subsequent 
imaging. Figure 4.2.1.1 (D) displays a magnified microscope image of a worm from this 
device immobilized in the trapping region. 
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Figure 4.2.1.1: Single-layer parallel immobilization microfluidic device. 
(A) A stereoscope image of a single-layer microfluidic device with one entrance, exit, 
and purge line leading to 40 parallel tapered immobilization channels. (B) Schematic 
showing the entrance and exit dimensions of the channel as well as the channel height. 
(C) A stereoscope image of immobilized day 3 adult JPS67 C. elegans in a single-layer 
device. (D) A microscope image of an immobilized adult C. elegans. The scale bar is 1 
mm (A), (C), and 200 µm (D). 
This single-layer PDMS chip showed promising results.  90% of the worms put 
into these devices are successfully immobilized in the tapered channels. This is achieved 
within 2 minutes using constant pressure from a syringe (by hand or by pump). While this 
design has successfully demonstrated rapid loading and immobilization of day 3 adult C. 
elegans, it does not fulfill an important criterion: the successful imaging of motor VC 
neurons that are the focus of our study. Greater than half of the immobilized worms are 
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oriented in an unfavorable position for fluorescent imaging of desired neurons. This led 
to our development of double-layer parallel immobilization chips. 
4.2.2  DOUBLE-LAYER PARALLEL IMMOBILIZATION MICROFLUIDIC DEVICES 
The goal of the double-layer mold PDMS chips is to not only rapidly immobilize the 
adult C. elegans, but improve the lateral orientation of the nematode during the filling of 
the traps. All of the subsequent double-layer devices consist of an array of 40 tapered 
parallel traps, each to immobilize a single adult C. elegans for fluorescent imaging and 
observation. Our double-layer device #1 is a simple one-layer PDMS chip fabricated 
from a two-layer SU8 mold on a silicon wafer. Figure 4.2.2.1 (A) displays a stereoscope 
image of two-layer device #1. This chip has one main inlet and has a height change at the 
entrance of the 40 parallel traps. There is a single exit connected to atmospheric pressure 
and a purge line to remove untrapped worms from the device. Figure 4.2.2.1 (B) shows a 
schematic of the immobilization channel entrance and exit dimensions as well as the 
channel heights, depicted in different colors, zone 1 (Z1, blue) and zone 2 (Z2, green). An 
enlarged image of the two-layer tapered immobilization channels as well as the location 
of the height change in the device is displayed in Figure 4.2.2.1 (C).  
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Figure 4.2.2.1: Double-layer parallel immobilization microfluidic device #1. 
(A) A stereoscope image of a double layer mold microfluidic device with one entrance, 
exit, and purge line leading to 40 parallel tapered immobilization channels.  (B) 
Schematic showing the entrance and exit dimensions of the tapered immobilization 
channel as well as the channel heights, depicted in different colors, zone 1 (Z1, blue) and 
zone 2 (Z2, green). (C) An enlarged stereoscope image of the tapered immobilization 
channels. The height change in this device occurs at the entrance of the tapered channels. 
The scale bar is 1 mm (A) and 200 µm (C).  
Our double-layer device #2 is a simple one-layer PDMS chip fabricated using a 
two-layer SU8 mold on a silicon wafer. A stereoscope image of double-layer device #2 is 
displayed in Figure 4.2.2.2 (A). This chip has one main inlet and has a height change that 
occurs 600 µm from the entrance of the tapered immobilization channels. There is a 
single exit connected to atmospheric pressure and a purge line to remove untrapped 
worms from the device. 
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Figure 4.2.2.2: Double-layer parallel immobilization microfluidic device #2. 
(A) A stereoscope image of a two-layer mold microfluidic device with one entrance, exit, 
and purge line leading to 40 parallel tapered immobilization channels.  (B) Schematic 
showing the entrance and exit dimensions of the tapered immobilization channel as well 
as the channel heights, depicted in different colors, zone 1 (Z1, blue) and zone 2 (Z2, 
green). (C) An enlarged stereoscope image of the tapered immobilization channels. The 
height change in this device occurs 600 µm from the entrance of the tapered channels. 
The scale bar is 1 mm (A) and 200 µm (C).  
Figure 4.2.2.2 (B) presents a schematic of the immobilization channel entrance and exit 
dimensions as well as the channel heights, depicted in different colors, zone 1 (Z1, blue) 
and zone 2 (Z2, green). Figure 4.2.2.2 (C) displays an enlarged image of the two-layer 
tapered immobilization channels as well as the location of the height change in this 
device. The scale bar is 1 mm in Figure 4.2.2.2 (A) and 200 µm in Figure 4.2.2.2 (C). 
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Our double-layer device #3 is another simple one-layer PDMS chip fabricated 
using a two-layer SU8 mold on a silicon wafer. Figure 4.2.2.3 (A) displays a stereoscope 
image of double-layer device #3.  
 
Figure 4.2.2.3: Double-layer parallel immobilization microfluidic device #3. 
(A) A stereoscope image of a two-layer mold microfluidic device with one entrance, exit, 
and purge line leading to 40 parallel tapered immobilization channels.  (B) Schematic 
showing the entrance and exit dimensions of the tapered immobilization channel as well 
as the channel heights, depicted in different colors, zone 1 (Z1, blue) and zone 2 (Z2, 
green). (C) An enlarged stereoscope image of the tapered immobilization channels. The 
height change in this device occurs 900 µm from the entrance of the tapered channels. 
The scale bar is 1 mm (A) and 200 µm (C).  
This chip has one main inlet and has a height change that occurs 900 µm from the 
entrance of the tapered immobilization channels. There is a single exit connected to 
atmospheric pressure and a purge line to remove untrapped worms from the device. 
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Figure 4.2.2.3 (B) shows a schematic of the immobilization channel entrance and exit 
dimensions as well as the channel heights, depicted in different colors, zone 1 (Z1, blue) 
and zone 2 (Z2, green). Figure 4.2.2.3 (C) displays an enlarged image of the two-layer 
tapered immobilization channels as well as the location of the height change in this 
device. 
These two-layer mold PDMS chips also achieved fast loading and immobilization 
in the tapered channels for 95% of the worms put into these devices. This was achieved 
within 3-5 minutes using constant pressure from a syringe (by hand or by pump) or with 
suction using a vacuum line. While this design also has successfully demonstrated rapid 
loading and immobilization of day 3 adult C. elegans, it still does not achieve the 
successful imaging of VC neurons that are the focus of our study. 45-50% of the 
immobilized worms are oriented in an unfavorable position for fluorescent imaging of the 
desired neurons in this two-layer device. This led to our development of three-layer 
parallel immobilization chips with more controlled and variable aspect ratios. 
4.2.3  TRIPLE-LAYER PARALLEL IMMOBILIZATION MICROFLUIDIC DEVICES 
The goal of the triple-layer parallel immobilization device is to immobilize the adult C. 
elegans rapidly and to control the orientation of the nematode during the filling of the 
traps. This triple-layer device consists of an array of 40 tapered parallel traps per well 
with variable aspect ratio along the channel length to immobilize and orient adult C. 
elegans for fluorescent imaging and observation. Our triple-layer device is a simple one-
layer PDMS chip fabricated using a three-layer SU8 mold on a silicon wafer. Figure 
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4.2.3.1 (A) displays a stereoscope image of a three-layer SU8 mold microfluidic device 
with one entrance leading to 40 parallel tapered immobilization channels and one exit. 
The three-layer device is rotated 90 degrees from the two- and one-layer devices to 
facilitate operation and imaging. Figure 4.2.3.1 (B) shows an enlarged stereoscope image 
of the tapered immobilization channels. The first height change in this device occurs 600 
µm from the entrance of the tapered channels. The second height change in this device 
occurs 1200 µm from the entrance of the tapered channels. Figure 4.2.3.1 (C) shows a 
schematic of the three-layer 40 channel device with three different device sections 
depicted in different colors, zone 1 (Z1, blue), zone 2 (Z2, green) and zone 3 (Z3, red). 
The colors represent different channel heights in the device. Also shown is a schematic 
giving the entrance and exit dimensions of the channel as well as the channel heights. A 
plot showing the aspect ratio (width to height) along the length of the three-layer 
immobilization channels is given in Figure 4.2.3.1 (D). The aspect ratio is calculated 
using the width of the tapering channel compared to the three constant channel heights.  
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Figure 4.2.3.1: Triple-layer parallel immobilization microfluidic device. 
(A) A stereoscope image of a three-layer SU8 mold microfluidic device with one 
entrance leading to 40 parallel tapered immobilization channels and one exit. (B) An 
enlarged stereoscope image of the tapered immobilization channels. The first and second 
height change in this device occurs 600 and 1200 µm respectively from the entrance of 
the tapered channels.  (C) Schematic of the three-layer 40 channel device with three 
different device sections depicted in different colors, zone 1 (Z1, blue), zone 2 (Z2, 
green) and zone 3 (Z3, red). The colors represent different channel heights in the device. 
The inset shows an enlarged schematic giving the entrance and exit dimensions of the 
channel as well as the channel heights. (D) A plot showing the aspect ratio (width to 
height) along the length of the three-layer immobilization channels. The scale bar is 1 
mm (A) and 500 µm (B).  
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This three-layer mold PDMS chip achieves fast loading and immobilization in the 
tapered channels with 95% trapping efficiency. This is achieved within 3-5 minutes using 
constant pressure from a syringe (by hand or by pump) or from a custom gasket system, 
discussed later in Chapter 4. Worm entrance and exit channels are fabricated with largest 
thickness (85 µm, shown in blue Figure 4.2.3.1 (C)) to reduce physical stress on worms 
inside the device during the loading process. Worms are found with reduced motion as 
they are pushed inside the device to the 65 µm (green) and 45 µm (red) sections with 
multiple immobilization pressure cycles. The width of the channel is varied along the 
length to achieve aspect ratio values within 1.2-0.4. Day 3 adult worms are immobilized 
in the region with ~1.0 aspect ratio. These channels are designed with a cross sectional 
areas of 7650 µm
2
 at the entrance and 900 µm
2
 at the end of the 3 mm long design. The 
tapering shape of the channel allows a 3 day adult C. elegans with an average body 
diameter of 75 µm to swim freely at the entrance, but get trapped as it moves along the 
length of the channel. This design not only successfully demonstrates rapid loading and 
immobilization of day 3 adult C. elegans; it also correctly orients the majority of the 
worms laterally for successful imaging of motor neurons VC1-VC6, which are the focus 
of this study. Around 90% of the immobilized worms are oriented in a favorable position 
for fluorescent imaging of the desired neurons in this triple-layer device. The triple-layer 
trapping channels with variable aspect ratios are designed based on worm size and 
morphology in order to coax the worm into a desired orientation for imaging of the VC 
neurons. 
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4.3 Multi-well format and flow rate characterization 
Total assay time in high-throughput studies is an important parameter.  By 
reducing experimental time per run, one can screen a larger number of compounds which 
increases the possibility of finding new hits in a chemical screen. In order to create a 
device that is high throughput and easy to load, we designed and tested connecting many 
chips together in a multi-well format. We designed our multi-well devices based on the 
standard 96-well plate format which can be integrated with enumerable robotic stations 
and liquid handling systems. A 96-well plate is used as an upper mold when fabricating 
our PDMS devices. In this process, we achieve an exact separation of 9 mm between 
each pair of wells embedded in the bulk PDMS layer. Each well exhibits a conical shape 
that connects to a single chip at the bottom. 
We started with a 1x2-well design by connecting two chips in parallel leading to a 
common exit. A schematic of the two sets of chips connected in parallel leading to a 
common exit is displayed in Figure 4.3.1 (A). The difference between the two devices is 
an altered entrance region, leading to different loading behaviors. The chip design with 
uniform rectangular entrance design achieved rapid immobilization with higher 
percentages of trapped worm in shorter time compared to the design with triangular 
entrance. After choosing the best entrance design we developed a 4x2 well devices where 
eight chips, wired in a pair of four identical chips, and connect to a single common exit. 
Figure 4.3.1 (B) shows a schematic of the 4x2-well design with four pairs of chips 
connected in parallel leading to a common exit. The 4x2-well devices are pressurized 
from a single pressure source with a simple custom built gasket.  Flow rates from a given 
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pressure source depend on the hydraulic resistances which are a function of the 
geometrical shape of the microfluidic channels. Since the primary contributor to the 
hydraulic resistance is exit channel length, flow rate decreases with the relative position 
of the well with respect to the outlet punch. The well situated on first row and closest to 
the exit presents minimum total hydraulic resistance and maximum flow rates (Figure 
4.3.3 (A)). Flow rate reduces by ~50% for the well which is farthest from the exit. The 
variation in the flow rates is more prominent at higher well pressures. To reduce the 
effect of well location on flow rates, hydraulic resistances are required to be modulated 
by compensating channel lengths with altered channel widths. For this, we designed an 
optimized 4x2-well device, as shown on the right side of Figure 4.3.1 (E). 
Hydraulic resistances are calculated for every section of an 8-well device with 
rectangular cross section (length (L), width (w), and width (h)) using Eq. (3). 
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The channel is assumed to be filled with a solution having viscosity (µ). The 3 mm long 
tapered immobilization channel is approximated with 600 segments of 5 µm long 
channels with varying cross sections connected in series. Figure 4.3.1 (C) and Figure 
4.3.1 (D) present a fluidic circuit representing the hydraulic resistance components for 
each section of the four sets of chips connected in parallel leading to a common exit. All 
resistances are connected with input and output pressure values of P and P0 respectively. 
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Figure 4.3.1: Development and flow optimization for multi-well three-layer 
microfluidic immobilization device designs. 
(A) Schematic of two sets of 1x2-well chips connected in parallel leading to a common 
exit. (B) Schematic of two different designs of 4x2-well chips with different entrance 
designs and connected in parallel to a common final exit. (C) Fluidic circuit representing 
the hydraulic resistance components for each section of the four sets of chips connected 
in parallel leading to a common exit and pressurized from one common source. (D) The 
same fluidic circuit rewritten and used for flow rate optimization. In both (C) and (D) the 
equivalent resistance of all 40 parallel trapping channels is connected in series with the 
exit flush arm and represented as RA, RB, RC, and RD for all 4x2 wells. The exit channel 
resistances are calculated separately as RDC, RCB, RBA, and RA0 between the junctions. All 
resistances are connected with input and output pressure values of P1 and P0 respectively. 
The hydraulic resistances are iteratively optimized to achieve similar values for flow rates 
QA, QB, QC, and QD using an equivalent circuit. (E) Schematic showing the initial design 
of the exit arm flush (left) and the optimized exit arm design (right) for the 4x2 devices. 
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The equivalent resistance of all 40 parallel trapping channels is connected in series with 
the exit flush arm and represented as RA, RB, RC, and RD for all 4x2 wells (Figure 4.3.1 
(C) and (D)). The resistances of the exit channels are calculated separately as RDC, RCB, 
RBA, and RA0 between the junctions. The hydraulic resistances are iteratively optimized to 
achieve similar values for the flow rates QA, QB, QC, and QD using the equivalent circuit 
in Figure 4.3.1 (D). Figure 4.3.1 (E) displays a schematic of the initial un-optimized 
design of the exit arm flush (left) compared to the optimized exit arm design (right) for 
the 4x2-well devices. Wells A1-B4 in Figure 4.3.1 (E) have identical channel designs but 
different net hydraulic resistances for every well up to the final exit.  Wells C1-D4 in 
Figure 4.3.1 (E) have different channel designs to achieve nearly identical hydraulic 
resistance up to the final exit, resulting in nearly identical flow rates from each well. 
Finally, using the optimized eight-well platform, we developed a comprehensive 
easy to use 96-well microfluidic system for high-throughput orientation, immobilization, 
and imaging of adult sized C. elegans.  Figure 4.3.2 (A) displays a schematic of the final 
96-well device, which is divided into smaller batches of 8-well sections each having a 
common exit port. Both pairs of 6 exit ports on the two sides of the PDMS block align 
with a common gasket exit grooves on each side (Exit 1 and Exit 2). Figure 4.3.2 (B) 
shows a schematic of the final 8-well optimized design used in the 96-well device. 
Figure 4.3.2 (C) shows the final chip design with the optimized exit channel and pillars 
added to improve structural integrity near the exits of the device. 
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Figure 4.3.2: Final high-throughput 96-well three-layer parallel immobilization 
microfluidic device. 
(A) Schematic of the final 96-well device, which is divided into smaller batches of 8-well 
sections, each connected together to one common exit port. Both pairs of 6 exit ports on 
the two sides of the PDMS block align with common gasket exit grooves on two sides 
(Exit 1 and Exit 2). (B) Schematic of the final 8-well optimized design used in the 96-
well device. (C) Schematic of the final chip design with the optimized exit channel. The 
three different device sections depicted in different colors, zone 1 (Z1, blue), zone 2 (Z2, 
green) and zone 3 (Z3, red), represent different channel heights in the device. 
Flow rates for the initial eight-well device with identical exit channel designs are 
presented in Figure 4.3.3 (A). Flow rates are measured using four different well 
pressures. Higher pressures produce a greater variation in flow rates between the wells. 
The optimized eight-well design with variable exit channel dimensions, giving nearly 
equivalent net hydraulic resistances, produces similar flow rates for all the wells, as 
displayed in Figure 4.3.3 (B). The optimized design is scaled up for the 96-well device, 
which shows similar trends for the flow rates from a section of wells located at the 
middle (A07-D07) and the edge (A01-D01) of a 96-well device, as shown in Figure 4.3.3 
(C). In an attempt to test the performance of the gasket system for all 96-well 
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immobilization chips, we measured the flow rates from one single exit connecting all 8 
wells under different opening condition. The flow rates measured from a single exit 
dropped by ~ 2% and 5% when all six and all 12 exit ports are open under 5 psi of gasket 
pressure as compared to when only a single exit is open, as shown in Figure 4.3.3 (D). 
 
Figure 4.3.3: Flow rate characterization of 8-well and 96-well devices. 
(A) Flow rates from a 4X2-well device with identical designs resulting in different flow 
rates. Flow rates are measured for four different well pressures. (B) Flow rates of a 4X2-
well device with different channel dimensions to achieve nearly similar hydraulic 
resistances. The dotted lines represent the theoretical flow rates as predicted from the 
resistance optimization. (C) Flow rates from wells at an extreme corner (A01, B01, C01 
and D01) and in the center (A07, B07, C07 and D07) of a 96-well device. (D) Exit port 
#3 flow rates with only the single exit port open, 6 exit ports open, and all 12 exit ports 
open under the same gasket pressure. Data represented as mean ± SD (n=4). 
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4.4 Gasket system 
To control, align, and house the 96-well microfluidic device, we designed and 
built a novel gasket microscope stage insert. This system can orient and immobilize the 
worms from all 96 devices simultaneously in one simple process using a single pressure 
source. The gasket system comprises of an acrylic top and an aluminum bottom piece. An 
acrylic sheet of 1/4 inch thickness is machined for the top gasket with one buffer entry 
port and one air vent. A volume of 4.4 inches x 3.0 inches x 1/8 inches is milled out at the 
center of the top gasket to hold sufficient buffer volume on top of the 96 wells embedded 
in the PDMS block. Two narrow lines are milled from the larger sides of the acrylic 
rectangle to connect all 6 exit punches on each side of the PDMS block. Both exit 
channels in the top-gasket are connected to an external waste reservoir using a luer 
connector fitted with a flexible tube. The size of the bottom gasket is machined to match 
the flat-top motorized microscope stage insert. Most of the material in the bottom gasket 
is removed from the middle to reduce material weight and enable fluorescence imaging in 
an inverted microscope. A small step in the metal gasket matches up with the dimension 
of the glass substrate of the PDMS device. The top and the bottom gasket pieces are held 
tight using six screws to avoid buffer leakage during pressurization. The device is 
operated using filtered M9 from a 500 mL reservoir that is pressurized using compressed 
air. The pressure is transmitted to the top gasket through a computer controlled solenoid 
valve. Figure 4.4.1 (A) gives a 3-dimensional model generated in AutoCAD 2013 
showing the bottom and top gasket pieces (Gasket-1 and Gasket-2 respectively), the inlet 
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and exits of the top gasket, and the 96-well device. Figure 4.4.1 (B) and (C) display an 
image of the device and gasket system both opened and closed. 
 
Figure 4.4.1: Gasket system designed for the 96-well microfluidic device. 
(A) A 3-dimensional model showing the bottom and top gasket pieces (Gasket-1 and 
Gasket-2 respectively), the inlet and exits of the top gasket, and the 96-well device. The 
model was generated using AutoCAD 2013. (B) Image showing the open gasket system 
containing a 96-well PDMS microfluidic device. (C) Image showing the closed gasket 
system containing a 96-well PDMS microfluidic device. 
4.5 Device assembly and application 
Our group has developed a high speed imaging platform for optical interrogation 
of adult C. elegans in a high-throughput manner. Figure 4.5.1 provides an outline of the 
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experimental procedure in the form of a flow chart. The chart is separated into three main 
steps with numerous subroutines. The main steps in order are 1) liquid culture worm 
maintenance, 2) device/worm preparation and immobilization, and 3) image acquisition 
and data analysis. The flow chart subroutines give an overview of the preparation, 
immobilization, optical interrogation, and data analysis of liquid culture grown day 3 
adult C. elegans in our high-throughput parallel immobilization 96-well microfluidic 
screening platform.  
 
Figure 4.5.1: Experimental procedure flow chart. 
A schematic showing the three main steps as well as an overview of the subroutines 
involved in the preparation, immobilization, optical interrogation, and data analysis of 
liquid culture grown day 3 adult C. elegans in our high-throughput parallel 
immobilization 96-well microfluidic system. 
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The screening platform consists of three major hardware components, a 96-well 
format immobilization device, a motorized stage, and a large field of view camera 
(Figure 4.5.2 (A)). The device is designed in PDMS material and is irreversibly bonded 
onto a 3 mm glass substrate. The PDMS block contains 96 conical shape wells which can 
hold ~120 µL liquid. Each of the well bottoms is expanded to 40 micro-fabricated 
channels for worm immobilization. The device is mounted onto an inverted microscope 
(IX73, Olympus) and held in place using our custom gasket system. The bottom 
aluminum gasket fits onto the flat-top motorized microscope stage and houses the glass 
substrate. The top gasket connects to all exits and allows one buffer pressure inlet line. 
The pressure in the top gasket is controlled using a computer controlled pressure valve. 
Fluorescence images of the trapped worms are acquired through a 10x, 0.3 NA objective 
using a 15x15 mm
2
 CCD camera. The camera captures 1.5 mm long portion of the ten 
parallel immobilization channels simultaneously with ~1 µm lateral resolution. A high 
resolution piezo stage acquires 12 image stacks with 5 µm step size to capture neuronal 
fluorescence located in different planes. Custom software controls the pressure valve, 
stage motion, and image acquisition. 
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Figure 4.5.2: Schematic of high-throughput platform used for optical interrogation 
of C. elegans.  
(A) Shows a schematic of the high-throughput platform developed for C. elegans 
imaging. The platform consists of a multi-well PDMS device clamped in between a 
gasket system (Gasket-1 and Gasket-2), pressurized by liquid pressure (Buffer), and 
mounted on a flat-top motorized stage. Fluorescence images of worms immobilized 
inside the microfluidic device are acquired using a 10x objective (0.3 NA) and a large 
field of view CCD camera (1.5x1.5 mm
2
). The stage, camera, and gasket pressure are 
controlled and automated using a computer that stores the image files sequentially. Stored 
images are analyzed and processed using a GUI for phenotyping neuronal health. The red 
box shows an example of GFP image of 10 worms immobilized inside the parallel traps. 
(B) Worms are immobilized inside the PDMS device using a computer controlled on-off 
pressure cycle using a pneumatic valve. Pressure cycles help to orient the worms inside 
channels. (C) Schematic of a section from the immobilization channel region and the 
cross-section of a single channel with an adult worm. Worms are relatively free in the 
first section (blue) and trapped in third section (red) with the ventral side oriented along 
the channel wall. Scale bar is 100 µm. 
The gasket system seals the chip during high pressure cycles for priming and 
immobilization. Devices are primed for 30 min at 5 psi buffer pressure to fill the whole 
chip with M9 buffer and to remove any air bubbles in the device. Worms loaded into the 
well sink to the bottom within 30 s and swim to the channel entrances. Worms in the 
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whole chip are pushed into the tapered channels using 4 psi gasket pressure. 
Immobilization pressure is turned ‘on’ and ‘off’ for 10 s each for a total of 10 cycles 
(Figure 4.5.2 (B)). Worms are pushed inside the channel during ‘on’ state and released 
free during the ‘off’ state to swim and orient themselves. During initial immobilization 
cycles, worms are freely swimming in channel entrances with 85 µm channel height. As 
worms are pushed inside the immobilization channel, they become immobile and not 
capable of changing their orientation. The aspect ratio of the device layers forces the 
worm to maintain lateral orientation as they are pushed into the channels from the 
entrances (Figure 4.5.2 (C)). The device is left with gasket pressure ‘on’ to keep the 
immobilized worms in position during imaging. Worms are found to release and escape 
from the traps with time in the absence of gasket pressure. Alignment features are imaged 
and measured for device calibration prior to the bright field and fluorescence imaging 
routine of the whole device. Images are saved in a storage computer and retrieved later 
for image processing. Images are loaded, processed, and scored to extract useful 
information such as percentages of healthy worm neurons, degenerated neurons, and 
worms that are not in good focus. This high-throughput system allows for large drug 
screens and rapid optical interrogation of 3840 adult C. elegans in our 96-well parallel 
immobilization microfluidic platform. 
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CHAPTER FIVE: HIGH-THROUGHPUT NEURODEGENERATION 
STUDIES IN C. ELEGANS ALZHEIMER’S DISEASE MODEL 
In this chapter, we present an application of our parallel immobilization 
microfluidic device for high-throughput optical interrogation of adult C. elegans. We 
begin by discussing the neuronal degeneration specific to this investigation. Then we 
describe the flow and operation of the 96-well device along with the plots and statistics 
from this study. Finally, we present the VC neuronal degeneration percentages of the 
control worm and the Alzheimer’s disease model worm in our high-throughput platform. 
5.1 VC motor neuron degeneration in C. elegans 
Two strains of C. elegans are utilized in this experiment. A wild type worm (WT) 
with green fluorescent protein (GFP) tagged VC neurons (LX959) and an Alzheimer’s 
disease model with a single copy of human APP and GFP tagged VC neurons (JPS67). A 
high-throughput drug screen or optical interrogation of C. elegans requires worm 
culturing and liquid handling in large quantities and in parallel. In order to facilitate these 
requirements, we have decided to adapt liquid culture maintenance of C. elegans, which 
can be modified to suit our need for drug treatment during a chemical screen. Worms are 
characterized by their vulva phenotype for drug treatment and/or application of 5-fluoro-
2'-deoxyuridine (FUdR), used to prevent eggs from becoming fertile and producing 
offspring during the study. They are administered for drug treatment at L4 stage and are 
used for screening and optical interrogation in devices at day 3 adult stage, 72 hours after 
L4 stage. Worms treated with FUdR at L4 stage in liquid cultures are picked and 
monitored for neuronal integrity at day1 adult, day 3 adult, and day 5 adult stages of 
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development. To understand the degeneration patterns, visible GFP signals are imaged on 
agar pads and scored for neuronal degeneration from wild type (LX959) and APP model 
(JPS67) grown in liquid culture and compared with NGM grown animals, as presented in 
Figure 5.1.1 (A) and (B). Degeneration percentages from liquid culture worms are 
similar to the degeneration rates from NGM worms.  
 
Figure 5.1.1: Alzheimer’s Disease model shows higher degeneration with age. 
(A) Fluorescence image of day 1 adult WT worm (LX959) grown in liquid culture (LC) 
showing healthy VC neurons. The inset shows high magnification image of VC4 and 
VC5 neuronal cell bodies of the same worm. (B) Fluorescence image of a day 3 adult 
APP mutant worm (JPS67). The inset shows fluorescence from a degenerating VC5 cell 
body from the same worm. The white arrows show all six VC neurons. (C and D) Show 
the comparison of VC4 and VC5 degeneration percentages of LX959 and JPS67 animals 
as a function of their developmental stage. Data represented as mean ± SEM (N>50 
animals and N>100 neurons). Scale bar is 10 µm. 
Wild type animals growing in liquid culture show 5% degeneration on day 1 stage that 
increased to 9% and 12% by day 3 and day 5 respectively. This is similar to the 
percentages found in wild type NGM grown worms (Figure 5.1.1 (C)). JPS67 worms 
show similar degeneration percentages on day 1 (13%), but much greater degeneration 
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percentages on day 3 (41%) and day 5 (53%), as compared to the wild type control. 
Similar trend is also observed from the worms growing on NGM plate (Figure 5.1.1 
(D)). Only day 5 stage worms are found to have statistically higher percentages of 
degeneration in liquid culture compared to the NGM grown worms. 
5.2 High-throughput optical interrogation of VC neuron health in adult 
C. elegans 
Many C. elegans studies, including manual drug screens, are limited to a small number of 
worms at a time due to various rate limiting factors such as worm immobilization in 
anesthetic solution, mounting a small number of worms on an agar pad, and manual stage 
motion to bring individual worms into the field of view for imaging. Using our 
microfluidic immobilization array, one can immobilize ~4000 worms in parallel to be 
imaged on top of a flat glass surface and 40 µm high PDMS channels. Worms growing in 
a 96-well plate are filtered and loaded directly into wells of the PDMS device using a 
multi-channel pipette. The 96-well device is clamped in between the gasket system 
before the worms are immobilized inside the channels. The device is mounted on a flat-
top motorized XY stage and equipped with a 500 µm piezo for Z movement. All 3-axis 
motions are controlled using an in-house LabVIEW algorithm, developed in our group. 
Wells are filled with approximately 60 day 3 adult worms in M9 and clamped with the 
gasket system to avoid pressure leakage during the immobilization cycle. The top gasket 
is filled slowly with M9 buffer under 0.5 psi pressure with an air vent open. The slow 
filling rate avoids worm mixing between wells due to spill over during buffer flow. 
Worms are able to swim freely at device entrances with the exits closed, but feel the 
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pressure as soon the exit is opened. Worms are immobilized using an on-off cycle of 4-5 
psi on the 96-well gasket system. Exit 1 and exit 2 are opened at same time on both sides 
to immobilize worms in all 96 wells simultaneously. The whole 96-well immobilization 
is achieved in less than 5 min and dispenses about 100 mL of buffer volume. One of the 
wells from D01-E12 is viewed with low magnification (2x, 0.06 NA) to monitor the 
extent of immobilization with cycle number. Once the immobilization cycle is complete, 
the stage is manually moved to record XYZ coordinates of wells A01, A12, H12, and 
H01 using a 10x, 0.3 NA objective to calibrate XY offset and the XZ tilt of the channel 
design with respect to the stage axes. The XYZ values are calculated for each position on 
the device and corrected before acquiring the image stacks. The microscope, equipped 
with a 15 x 15 mm
2
 active area and a 10x, 0.3 NA objective, is moved at four successive 
locations to capture all 40 traps filled with worms per well. Figure 5.2.1 (A) and (B) 
demonstrates this lateral movement. At each location, 12 z-stack images are taken at 5 
µm intervals to capture neuronal fluorescence located in different planes. A total of 4608 
fluorescent z-stack images are acquired from the whole 96-well device in less than 12 
minutes. Using this system, greater than 90% of the worms are scored for all 96 wells. 
Approximately 95% of the immobilization channels per well are filled with worms using 
our immobilization method, as presented in Figure 5.2.1 (C). Worms inside the channels 
do not show any bias for head-tail orientation (55 ± 10%, mean ± SD), as depicted in 
Figure 5.2.1 (D). This worm immobilization system provides a uniform platform for 
high-throughput phenotyping and screening using fluorescent based imaging.  
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Figure 5.2.1: Stage motion and contour plot of worm immobilization parameters 
from the 96-well device.  
Day 3 old JPS67 worms are immobilized in the 96-well device using 5 psi pressure on the 
top-gasket. (A) Schematic of the XY stage movement parameters between two 
consecutive devices. (B) Low resolution image of worms immobilized in the device 
under well #A11. Parallel traps are imaged with a large camera to capture 1.5 x 1.5 mm 
and moved in a synchronized manner to acquire 12 z-stack images at every location. (C) 
Shows the immobilization efficiency map of adult worms from an individual experiment 
with the 96-well parallel immobilization device. (D) Shows the head-tail orientation of 
the trapped worms from all 96-well devices with 40 traps per device. 
One whole screening of a 96-well device would capture 4608 fluorescent images 
to be able to phenotype neuronal health from 96 populations in less than 12 minutes. A 
manual analysis of such a large data set would be a rate limiting factor. Our research 
group has developed a Graphical User Interface (GUI) based semi-automated image 
processing algorithm to simplify manual data handling and decrease image analysis time. 
The GUI has three major parts, locating the worms in the channels, finding the best plane 
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of focus, and loading cropped images of individual worms for manual scoring. The user 
can extract the scores to plot them graphically and perform statistical analysis. Figure 
5.2.2 (A) shows a fluorescent image of day 3 adult JPS67 worms immobilized in our 96-
well device during an experiment. Cropped worm images are loaded one at a time for 
scoring, as displayed in Figure 5.2.2 (B). The z-stack image with the best plane of focus 
for VC4 and VC5 of an individual worm is displayed for scoring, as presented in Figure 
5.2.2 (C).  
 
Figure 5.2.2: Scoring of AD model worms (JPS67) in the 96-well parallel 
immobilization device. 
(A) Fluorescent image of day 3 adult JPS67 worms immobilized in the 96-well device. 
Image taken from a large field of view camera with a 10x 0.3 NA objective using an 
inverted microscope (Olympus IX73). (B) Cropped fluorescent image of one worm 
located with the image processing algorithm. (C) Enlarged and cropped fluorescent image 
of the same worm showing the best plane of focus for VC4 and VC5. The VC4 neuron is 
healthy while the VC5 neuron is degenerated. 
A complete set of images from a full 96-well experiment requires approximately 8 
hours to score the ~3840 channels filled with worms for VC neuronal health using our 
semi-automated GUI. Every single worm is inspected and a score is assigned for VC4 
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and VC5 in the GUI with an additional remark on the neuronal process. VC4 and VC5 
neurons are scored as ‘Normal’, ‘Degenerated’, or ‘Do Not Score’ if they are ‘healthy’, 
‘dim/missing’, or ‘not in focus’ respectively. The whole worm is assigned with an 
additional score for ‘Dim Worm’, ‘Neurons Misshapen’, and/or ‘Axon Beading’ if the 
whole worm is out of focus, VC4/VC5 cell bodies are misshapen, and/or neuronal 
process are beaded. The scores for all worms are saved in an array and are assigned with 
complete identification of the worm. Scores from all 40 traps per well are pulled together 
to find out degeneration percentages for each population. In one experiment, all 96 wells 
from one device are loaded with WT worms (LX959) and all 96 wells from another 
device are loaded with APP worms (JPS67). Figure 5.2.3 (A) shows the scored VC 
neuron degeneration percentages from the whole device with a mixture of LX959 and 
JPS67 worms. Day 3 adult stage LX959 control worms show a degeneration of 7 ± 4% 
(mean ± SD) as compared to JPS67 that shows 24 ± 7% when scored on our high-
throughput imaging platform, as displayed in Figure 5.2.3 (B).  
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Figure 5.2.3: Semi-automate scoring algorithm with WT (LX959) and APP model 
(JPS67) worms on high-throughput platform.  
(A) Shows the scores of a 96-well device loaded with D3 stage wild type (LX959) worms 
and APP model (JPS67) worms. Degeneration scores from individual wells are 
represented as shades of green or red. JPS67 worms are loaded into wells A01-H03 and 
LX959 worms are loaded into the remaining wells. (B) Scatter plot from all 96 wells for 
both LX959 (green) and JPS67 (red).  
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CHAPTER SIX: CONCLUSIONS AND FUTURE DIRECTIONS 
6.1 Conclusions 
Numerous microfluidic technologies are available for C. elegans research to 
understand the neurobiology of nerve regeneration [4], stress response of individually 
confined worms [22], and to facilitate fluorescent based screening [9-11] in vivo. Most of 
these technologies are laboratory scale since they require complicated valve control, long 
pre-treatment, serial sample processing, difficult protocols, and are incompatible to 
existing sample handling. In this thesis, we described the development of a multiple 
parallel immobilization microfluidic device leading to our triple-layer 96-well 
microfluidic platform for high-throughput optical interrogation of adult C. elegans. Our 
final 96-well microfluidic based technology has a single pressure input, zero valve 
control, 30 min pre-conditioning, parallel sample handling, is compatible to multi-well 
plate handling, and has an easy protocol for non-technologists. The device has twelve 
segments of 8-well platforms and can be manufactured as a multiple of 8-well 
configurations. A minimum requirement of one pressure line with maximum 5 psi would 
allow the user to run the whole chip with an appropriate gasket design. Users are allowed 
to select any rectangular size well array on the chip to be able to scan predefined well 
numbers. One complete experiment dispenses ~100 mL of buffer during the whole 96 
well experiment. All 96 wells with 40 immobilization channels immobilized 
approximately 3840 worm in less than 5 min. A shorter immobilization step is very 
advantageous for sensitive C. elegans screens with weaker expression level of fluorescent 
reporters. Worms immobilized inside the channel can encounter higher level of stress 
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causing increased auto fluorescence, thus reducing the sensitivity of the screen (poor 
signal to background ratio). 
With an in-house automated imaging platform, we can capture all 40 channels per 
well in a whole 96-well device in less than 12 min using 10x objective (0.3 NA) and a 
large field-of-view camera. One full chip scan generates 4608 images of ~ 40 GB data 
from 3840 worms. The chip is also capable of enabling high resolution imaging screens 
with higher numerical aperture objectives that would require more z-stacks. A higher NA 
objective with a smaller field of view would require an increased number of imaging 
locations to cover the whole length and all 40 channels. Our research group has 
developed data management through a LabVIEW acquisition system and has developed a 
separate GUI to analyze fluorescence signals semi-automatically for neuronal 
phenotypes. Utilizing this GUI, we scored all 3840 channels from a whole 96-well chip in 
approximately 8 hours. All the scores are pooled together from the multi-dimensional 
array and displayed for statistical tests. 
This screening platform can easily be adapted by a research laboratory for 
imaging based studies that require large population size phenotyping. Since the device 
interface is formatted for the standard 96-well platform, the technology can be a great 
value for commercial infrastructure for large scale high-throughput screening for C. 
elegans.  
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6.2 Future directions 
Our research group is working towards a complete automated image processing 
algorithm to focus on a specific neurodegenerative disease model where the complete 
data can be analyzed in less than 30 min. Even though we have used D3 stage C. elegans 
in our screen, one can use the same design principle for different stage of the worm with 
altered device dimensions to achieve similar efficiency of immobilization. A younger 
stage worm requires, for example, smaller device dimensions which can allow expansion 
of the 96-well format to larger well formats.  
With this in mind, we have designed, optimized, and fabricated numerous triple-
layer microfluidic devices for L4 to young adult stage C. elegans. These devices are 
designed to rapidly orient and immobilize L4 stage worms for semi-automated axotomies 
using femtosecond laser pulses, optical interrogation of neuronal regeneration post 
axotomy, and automated high-speed confocal imaging studies in L4 stage C. elegans. 
Figure 6.2.1 displays the first set of device designs fabricated and tested for these 
studies. The devices shown in Figure 6.2.1 (D-F) have multiple exits leading to either 
individual or double channels to enable long terms studies. Multiple exits allow for 
precise removal of individual worms or sets of consecutive worms from their trapping 
channels after each imaging and/or axotomy procedure. These devices are designed to 
run with L4 stage worms (zdIs5) to test the immobilization and orientation of each 
design. The worms are sent into the devices using a single liquid pressure source of 5 psi 
gauge. Each design proved to immobilize and orient over 90% of the worms. 
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Figure 6.2.1: Triple-layer parallel immobilization microfluidic devices for semi-
automated axotomies, neuronal regeneration, and automated high-
speed confocal imaging studies in L4 stage C. elegans. 
The heights and geometries of these devices have been optimized to orient and 
immobilize L4 to young adult stage C. elegans for semi-automated axotomies, optical 
interrogation, and automated high-speed high-resolution confocal imaging. The three 
different device sections depicted in blue, green, and red represent heights of 55 µm, 40 
µm, and 22 µm respectively. (A) Schematic of a device with 26 channels, each separated 
by 150 µm. (B) Schematic of a device with 32 channels, each separated by 125 µm. (C) 
Schematic of a device with 40 channels, each separated by 100 µm. (D-F) The 
immobilization channels in these devices are separated by 200 µm. (D) Schematic of a 
device with 5 channels and 5 exits. Each exit can be used to control or remove individual 
worms. (E) Schematic of a device with 8 channels and 8 exits, which can be used to 
control or remove individual worms. (F) Schematic of a device with 16 channels and 8 
exits. Each of these exits can be used to control or remove two consecutive worms.  
In collaboration with Kutal Gokce, the 8-channel and the 26-channel devices are then 
used to immobilize L4 zdIs5 worms for semi-automated axotomies of the ALM neurons 
and post-surgery imaging. Figure 6.2.2 (A) and Figure 6.2.3 (A) show images of the 
immobilized worms in the 8-channel and 26-channel devices, respectively. Figure 6.2.2 
(B) and Figure 6.2.3 (B) show high-resolution images of axons of the ALM neuron cut 
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using femtosecond laser pulses. Figure 6.2.2 (C) and Figure 6.2.3 (C) show images of 
the same worms immobilized in the device 24 hours post axotomy. Figure 6.2.2 (D) and 
Figure 6.2.3 (D) show high-resolution images of the axonal regrowth 24 hours post-
surgery. 
 
Figure 6.2.2: Semi-automated axotomy experiment using our 8 channel three-layer 
parallel immobilization microfluidic device with 8 exits. 
Successful axotomies were performed on the ALM of 7 out of the 8 immobilized zdIs5 
worms, due to proper orientation in the device. (A) Image of immobilized L4 stage zdIs5 
worms in our 8 channel device. (B) High-resolution post axotomy image of the ALM cut 
with a femtosecond laser pulse. The red arrow indicates the location of the cut. (C) Image 
of the same worms immobilized 24 hours later in our 8 channel device. The device was 
left with a slow perfusion of S. medium with HB101 bacteria in a 16.5 °C incubator. (D) 
High-resolution image of regrowth and reattachment of the ALM axon. 
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Figure 6.2.3: Semi-automated axotomy experiment using our 26 channel three-layer 
parallel immobilization microfluidic device. 
Successful axotomies were performed on the ALM of 21 out of the 23 immobilized zdIs5 
worms. (A) Image of immobilized L4 stage zdIs5 worms in our 26 channel device. (B) 
High-resolution post axotomy image of the ALM cut with a femtosecond laser pulse. The 
red arrow indicates the location of the cut. (C) Image of the same worms immobilized 24 
hours later in our 26 channel device. The device was left with a slow perfusion of S. 
medium with HB101 bacteria in a 16.5 °C incubator. (D) High-resolution image of 
regrowth and reattachment of the ALM axon. 
After successful axotomies are performed on over 90% of the immobilized 
worms, the devices are put into a 16.5 °C incubator with a slow perfusion of HB101 
bacteria in S. medium through the device entrance for 24 hours. The worms are then re-
trapped in the immobilization channels for post-surgery imaging to understand the level 
of axon regrowth. This time the worms were immobilized and oriented with around 50% 
efficiency. This low efficiency is most likely due to the worms getting immobilized in the 
channels during the 24 hour housing as they are pushed into the trapping channels by the 
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flow of nutrient perfusion from the device entrance to the channel exits. Worms were 
found either unhealthy or dead in the channels of the device.  
In order to successfully house the worms indefinitely for subsequent imaging and 
regeneration studies, we have designed a new device with side perfusion channels to 
allow a slow nutrient perfusion through the housing area of the device. The slow 
perfusion rates is expected to allow worms to swim freely without getting forced into the 
immobilization channels during the post-surgery incubation. Figure 6.2.4 shows the 
triple-layer parallel immobilization microfluidic device design with perfusion sieve 
structures. We are currently testing the performance of these devices for nerve 
regeneration studies that require housing of worms for at least 24 hours. 
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Figure 6.2.4: Triple-layer parallel immobilization microfluidic device with perfusion 
sieve structures used to house post axotomy L4 stage C. elegans 
indefinitely. 
The heights and geometries of this device have been optimized to orient and immobilize 
L4 to young adult stage C. elegans for semi-automated axotomies. The sieve structures 
allow a slow nutrient perfusion for housing the worms for 24 hours before high-speed 
high-resolution confocal imaging. The three different device sections depicted in blue, 
green, and red represent heights of 55 µm, 44 µm, and 24 µm respectively. (A) Schematic 
of a device with 26 immobilization channels, each separated by 150 µm. The device also 
has an entrance area that will allow nutrient perfusion for indefinite housing of the 
worms. (B) An enlarged schematic of the perfusion sieve structures. (C) Schematic of the 
top and front geometries of the perfusion windows.  
Finally, we have designed an initial 384-well parallel immobilization device for 
ultrafast high-throughput immobilization and imaging of L4 stage C. elegans. Figure 
6.2.5 presents the initial 384-well design. Each well leads to parallel immobilization 
channels designed to orient and immobilize 30 L4 stage worms, for a total of 11,520 
worms.  
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Figure 6.2.5: Ultra high-throughput 384-well three-layer parallel immobilization 
microfluidic device. 
(A) Schematic of a 384-well device design, which is divided into smaller batches of 8-
well sections connected together to one common exit port. Both pairs of 25 exit ports on 
the two sides of the PDMS block align with the common gasket exit grooves on the two 
sides (Exit 1 and Exit 2). (B) Schematic of the 8-well optimized design used in the 384-
well device. (C) Schematic of the final chip design with the optimized exit channel. This 
design, with 30 immobilization channels per well, has the ability to rapidly immobilize 
11,520 worms for optical interrogation. The three different device sections depicted in 
blue, green, and red represent heights of 55 µm, 40 µm, and 22 µm respectively. 
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This 384-well platform can be run with the same gasket setup described in the 
thesis. Since the device interface is formatted for the standard 384-well platform, the 
technology can be a great value for commercial research labs and large scale high-
throughput screening for C. elegans. It can be utilized to study Alzheimer’s Disease, 
Huntington’s Disease, nerve regeneration in the ALM neuron’s axon, and many other 
neurodegenerative disorders. 
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